Literature DB >> 7503684

Host cell antigenic profile acquired by HIV-1 is a marker of its cellular origin.

I Abbate1, M R Capobianchi, S Fais, C Castilletti, F Mercuri, P Cordiali Fei, F Ameglio, F Dianzani.   

Abstract

HIV-1 acquires cell membrane proteins during budding. The cell membrane proteins (CMP) profile of laboratory HIV-1 strains grown in different host cells was established, by using an immobilized antibody capture (IAC), to verify whether CMPs present on HIV-1 correlate with its host cell origin. HIV-1 grown in different cell lines incorporates cell markers such as CD3, CD19, CD14, CD31 and IL 2-R, according to the distinctive expression of these antigens on the host cells. Furthermore, also T-tropic and monocytotropic HIV-1 strains display host cell specific markers, supporting the hypothesis that virus associated CMPs are a marker of host cell origin.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7503684     DOI: 10.1007/bf01384347

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  20 in total

1.  Characterization of EN4 monoclonal antibody: a reagent with CD31 specificity.

Authors:  V L Burgio; S Zupo; S Roncella; M Zocchi; L P Ruco; C D Baroni
Journal:  Clin Exp Immunol       Date:  1994-04       Impact factor: 4.330

2.  HIV type 1 grown on interferon gamma-treated U937 cells shows selective increase in virion-associated intercellular adhesion molecule 1 and HLA-DR and enhanced infectivity for CD4-negative cells.

Authors:  C Castilletti; M R Capobianchi; S Fais; I Abbate; B Ficociello; F Ameglio; P Cordiali Fei; S M Santini; F Dianzani
Journal:  AIDS Res Hum Retroviruses       Date:  1995-05       Impact factor: 2.205

3.  Unidirectional budding of HIV-1 at the site of cell-to-cell contact is associated with co-polarization of intercellular adhesion molecules and HIV-1 viral matrix protein.

Authors:  S Fais; M R Capobianchi; I Abbate; C Castilletti; M Gentile; P Cordiali Fei; F Ameglio; F Dianzani
Journal:  AIDS       Date:  1995-04       Impact factor: 4.177

Review 4.  The immunopathogenesis of human immunodeficiency virus infection.

Authors:  G Pantaleo; C Graziosi; A S Fauci
Journal:  N Engl J Med       Date:  1993-02-04       Impact factor: 91.245

5.  Synthetic peptide analogs of intercellular adhesion molecule 1 (ICAM-1) inhibit HIV-1 replication in MT-2 cells.

Authors:  J V Fecondo; N C Pavuk; K A Silburn; D M Read; A S Mansell; A W Boyd; D A McPhee
Journal:  AIDS Res Hum Retroviruses       Date:  1993-08       Impact factor: 2.205

6.  Cellular proteins bound to immunodeficiency viruses: implications for pathogenesis and vaccines.

Authors:  L O Arthur; J W Bess; R C Sowder; R E Benveniste; D L Mann; J C Chermann; L E Henderson
Journal:  Science       Date:  1992-12-18       Impact factor: 47.728

7.  Association of host cell surface adhesion receptors and other membrane proteins with HIV and SIV.

Authors:  R J Orentas; J E Hildreth
Journal:  AIDS Res Hum Retroviruses       Date:  1993-11       Impact factor: 2.205

8.  Comparison of viral burden and phenotype of HIV-1 isolates from lymph nodes and blood.

Authors:  C Tamalet; A Lafeuillade; N Yahi; C Vignoli; C Tourres; P Pellegrino; P de Micco
Journal:  AIDS       Date:  1994-08       Impact factor: 4.177

9.  In vivo T lymphocyte origin of macrophage-tropic strains of HIV. Role of monocytes during in vitro isolation and in vivo infection.

Authors:  F E Massari; G Poli; S M Schnittman; M C Psallidopoulos; V Davey; A S Fauci
Journal:  J Immunol       Date:  1990-06-15       Impact factor: 5.422

10.  Syncytium-inducing and non-syncytium-inducing capacity of human immunodeficiency virus type 1 subtypes other than B: phenotypic and genotypic characteristics. WHO Network for HIV Isolation and Characterization.

Authors:  F De Wolf; E Hogervorst; J Goudsmit; E M Fenyö; H Rübsamen-Waigmann; H Holmes; B Galvao-Castro; E Karita; C Wasi; S D Sempala
Journal:  AIDS Res Hum Retroviruses       Date:  1994-11       Impact factor: 2.205

View more
  2 in total

1.  T cells expressing activated LFA-1 are more susceptible to infection with human immunodeficiency virus type 1 particles bearing host-encoded ICAM-1.

Authors:  J F Fortin; R Cantin; M J Tremblay
Journal:  J Virol       Date:  1998-03       Impact factor: 5.103

2.  Antigen-presenting particle technology using inactivated surface-engineered viruses: induction of immune responses against infectious agents.

Authors:  Joseph D Mosca; Yung-Nien Chang; Gregory Williams
Journal:  Retrovirology       Date:  2007-05-15       Impact factor: 4.602

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.